
-
2012
Company Description
ILiAD is a clinical stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis.
ILiAD Biotechnologies, LLC (ILiAD) is a clinical stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis. ILiAD's lead candidate is BPZE1, a live-attenuated pertussis vaccine that has successfully completed a Phase 1 human clinical trial.
-
Manufacturer:
Science and Engineering -
Formed:
2012 -
Founders:
Keith Rubin -
Company Website:
-
Company E-mail:
-
Company Address:
230 East 15th StreetNew York, NYUnited States -
CEO:
- Keith Rubin
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits